Department of Internal Medicine V, (Complementary and Integrative Medicine), University of Duisburg-Essen, Kliniken Essen-Mitte, Germany.
Rheumatology (Oxford). 2010 Apr;49(4):778-88. doi: 10.1093/rheumatology/kep439. Epub 2010 Jan 25.
To systematically review the efficacy of acupuncture in fibromyalgia syndrome (FMS).
MEDLINE, PsychInfo, EMBASE, CAMBASE and the Cochrane Library were screened (through July 2009). The reference sections of original studies and systematic reviews for randomized controlled trials (RCTs) on acupuncture in FMS were searched.
Seven RCTs with a median treatment time of 9 (range 6-25) sessions and 385 patients were included. Outcomes of interest were key symptoms of FMS, namely pain, fatigue, sleep disturbances, reduced physical function and side effects at post-treatment. Follow-up of two RCTs with a median follow-up of 26 weeks was available. Standardized mean differences (SMDs) comparing verum and control acupuncture were calculated. Strong evidence for the reduction of pain (SMD -0.25; 95% CI -0.49, -0.02; P = 0.04) was found at post-treatment. There was no evidence for the reduction of fatigue and sleep disturbances, or the improvement of physical function at post-treatment. There was no evidence for the reduction of pain and improvement of physical function at the latest follow-up. Subgroup analyses resulted in moderate evidence for a significant and small reduction of pain at post-treatment in studies with electro-stimulation and individualized acupuncture. Stratifying the type of controls (penetrating vs non-penetrating control acupuncture) did not change the results. Significant reduction of pain was only present in studies with risk of bias. Side effects were inconsistently reported.
A small analgesic effect of acupuncture was present, which, however, was not clearly distinguishable from bias. Thus, acupuncture cannot be recommended for the management of FMS.
系统评价针刺治疗纤维肌痛综合征(fibromyalgia syndrome,FMS)的疗效。
计算机检索 MEDLINE、PsychInfo、EMBASE、CAMBASE 和 Cochrane Library(2009 年 7 月),并手工检索纳入研究的参考文献和针刺治疗 FMS 的系统评价,纳入针刺治疗 FMS 的随机对照试验(randomized controlled trial,RCT)。
共纳入 7 项 RCT,治疗时间中位数为 9 (范围 6-25)个疗程,患者 385 例。观察指标为 FMS 的主要症状,即疼痛、疲劳、睡眠障碍、躯体功能下降和不良反应。2 项 RCT 有 26 周的随访,计算标准化均数差值(standardized mean difference,SMD)。治疗后,针刺组疼痛改善优于对照组,差异有统计学意义[SMD=-0.25,95%CI(-0.49,-0.02),P=0.04];针刺组对疲劳和睡眠障碍、躯体功能的改善与对照组差异无统计学意义。针刺组的疼痛和躯体功能改善在随访时与对照组差异无统计学意义。亚组分析显示,电针和个体化针刺组在治疗后疼痛改善的差异有统计学意义,强度为中度;而常规针刺组治疗后疼痛改善的差异无统计学意义。根据对照方法(穿透性和非穿透性)分组,结果无变化。只有在低偏倚风险的研究中针刺组才显示出显著的镇痛作用。不良反应的报道不一致。
针刺治疗 FMS 有轻度的镇痛效果,但可能与偏倚有关,因此不能推荐针刺用于 FMS 的治疗。